Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027
Whether for treatment or prevention, women’s interest in injectable antiretrovirals varied based on their relationship with injection.
The updated HIV plan, released by the federal health department, offers a road map for the next five years.
North Dakota and Missouri bills focus on PrEP prescriptions, needle exchanges and HIV criminalization.
Journal retracts study that claimed that people who used condoms for HIV prevention were smarter than those who don’t.
The U.S. government and HIV drugmaker Gilead Sciences continue to fight over patents for Truvada and Descovy as PrEP.
Nearly eight years after Truvada’s approval for HIV prevention, primary care providers struggle to understand—and prescribe—the pill.
Please help Peter Staley reach his birthday goal!
PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.
These Florida and Maryland communities can access HIV tests, PrEP and overdose prevention via an RV and a van.
Researchers found that Truvada as pre-exposure prophylaxis greatly reduced HIV cases in both people on PrEP and those not on it.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
“All insurers failing to offer PrEP without cost sharing beginning in January 2021 are clearly not following the law.”
A new PrEP telehealth system at Stanford Children’s Health offers HIV prevention to youth and adults 25 and younger.
Fosters interdisciplinary knowledge-exchange on HIV vaccines, microbicides, PrEP, treatment as prevention and biomedical interventions.
The fifth annual Biomedical HIV Prevention Summit will be held as a virtual conference.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.